Monoclonal antibody inhibitors targeting vascular endothelial growth factor for retinal disorders. Delivered via intravitreal injection in ophthalmology clinics and retinal centers. Sourced by eye care providers from pharmaceutical manufacturers for macular degeneration therapy.